Table 2.
Pre-TEPS details of patients
| No. | Sex | Age | Obstruction site | Etiology | CP score | MELD score | Clinical manifestation | Treatment history | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PV | SMV | SV | bellyache | EGVB | Ascites | EVL/ESVD | LVP | Anticoagulation | Splenectomy | TIPS | BRTO | LT | ||||||
| 1 | M | 39 | + | − | − | HBV | 10 | 15 | − | + | +++ | + | + | − | − | − | − | − |
| 2 | F | 74 | + | + | + | PBC | 8 | 3 | − | − | +++ | − | + | − | − | − | − | − |
| 3 | M | 48 | + | − | − | HBV | 11 | 20 | − | + | − | − | − | − | − | − | + | − |
| 4 | M | 39 | + | − | − | HBV | 6 | 13 | − | + | + | − | − | + | − | − | − | + |
| 5 | M | 43 | + | + | − | HBV | 5 | 10 | − | + | − | + | − | + | − | + | − | − |
| 6 | M | 58 | + | + | − | BCS | 11 | 17 | − | − | +++ | − | + | + | − | − | − | − |
| 7 | M | 52 | + | − | + | HBV | 10 | 13 | − | + | +++ | + | + | + | − | − | − | − |
| 8 | M | 50 | + | + | N/A | HBV | 7 | 9 | − | + | − | + | − | + | + | + | − | − |
| 9 | M | 39 | + | − | N/A | HBV | 9 | 11 | + | + | + | + | − | + | + | + | − | − |
| 10 | F | 60 | + | − | N/A | Unknown | 6 | 7 | − | + | + | + | − | − | + | − | − | − |
| 11 | F | 50 | + | + | N/A | SOS | 10 | 8 | − | + | +++ | − | − | − | + | − | − | − |
| 12 | F | 62 | + | − | + | PBC | 7 | 3 | − | + | + + | + | − | − | − | − | − | − |
| 13 | F | 40 | + | + | + | Unknown | 5 | 7 | − | + | − | + | − | + | − | − | − | − |
| 14 | F | 58 | + | − | − | Unknown | 6 | 7 | − | + | − | − | − | − | − | − | − | − |
| 15 | F | 49 | + | + | − | PBC | 8 | 3 | − | + | − | − | − | − | − | − | − | − |
| 16 | F | 52 | + | − | + | PMF | 7 | 13 | − | + | − | + | − | + | − | + | − | − |
| 17 | M | 69 | + | − | − | HBV | 10 | 13 | − | + | +++ | + | + | + | − | − | − | − |
| 18 | M | 58 | + | + | N/A | HBV | 6 | 10 | + | − | + | − | − | + | + | − | − | − |
| 19 | M | 76 | + | − | N/A | HBV | 9 | 7 | − | − | +++ | − | + | − | + | + | − | − |
| 20 | M | 73 | + | − | + | HBV | 7 | 12 | − | + | + + | + | − | − | − | − | − | − |
| 21 | M | 53 | + | − | N/A | HBV | 9 | 7 | − | + | + + | + | − | − | + | + | − | − |
| 22 | M | 74 | + | − | − | HBV | 8 | 12 | − | + | + + | + | − | − | − | + | − | − |
PV Portal vein, SMV Superior mesenteric vein, SV Splenic vein, N/A not applicable or not available, BCS Budd Chiari syndrome, SOS Sinusoidal obstruction syndrome, PBC Primary biliary cirrhosis, PMF primary myelofibrosis, CP score Child–Pugh score, MELD score Model for End-stage Liver Disease, EGVB Esophageal and gastric varices bleeding, EVL Endoscopic variceal ligation, ESVD Endoscopic selective varices devascularization, LVP large-volume paracentesis, TIPS Transjugular intrahepatic portosystemic shunt, BRTO Balloon-occluded retrograde transvenous obliteration, LT Liver transplantation